Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer (Q37885319)

24 August 2017

1 reference

title

Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer (English)

1 reference

24 August 2017

0 references

0 references

1 reference

1 reference

1 reference

D Ansari

1

1 reference

24 August 2017

A Rosendahl

series ordinal

2

1 reference

24 August 2017

J Elebro

series ordinal

3

1 reference

24 August 2017

R Andersson

series ordinal

4

1 reference

24 August 2017

language of work or name

English

0 references

publication date

6 June 2011

1 reference

British Journal of Surgery

24 August 2017

1 reference

24 August 2017

98

1 reference

24 August 2017

8

1 reference

24 August 2017

1041-1055

1 reference

24 August 2017

Cancer statistics, 2009

1 reference

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2018

1 reference

Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors

21 January 2018

1 reference

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience

21 January 2018

1 reference

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

21 January 2018

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis

21 January 2018

1 reference

Reporting recommendations for tumor marker prognostic studies (REMARK).

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

The Hallmarks of Cancer

1 reference

Prognostic significance of activated Akt expression in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Cyclin E Expression and Outcome in Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material

21 January 2018

1 reference

Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer.

21 January 2018

1 reference

HER2 overexpression correlates with survival after curative resection of pancreatic cancer.

21 January 2018

1 reference

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival

21 January 2018

1 reference

Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Clinical significance of midkine expression in pancreatic head carcinoma

21 January 2018

1 reference

Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling

21 January 2018

1 reference

Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray

21 January 2018

1 reference

Loss of p27 expression is associated with poor prognosis in stage I-II pancreatic cancer.

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.

21 January 2018

1 reference

Correlation between TGF-beta1 and p21 (WAF1/CIP1) expression and prognosis in resectable invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

Clinicopathological significance of Bcl-2 and Bax protein expression in human pancreatic cancer

21 January 2018

1 reference

Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients.

21 January 2018

1 reference

XAF1 as a prognostic biomarker and therapeutic target in pancreatic cancer

21 January 2018

1 reference

Prognostic significance of angiogenesis in human pancreatic cancer

21 January 2018

1 reference

Angiogenesis in pancreatic carcinoma: thymidine phosphorylase expression in stromal cells and intratumoral microvessel density as independent predictors of overall and relapse-free survival

21 January 2018

1 reference

Cyclooxygenase-2 expression correlates with poor prognosis in pancreatic cancer.

21 January 2018

1 reference

Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer

21 January 2018

1 reference

Dkk-3 expression in the tumor endothelium: a novel prognostic marker of pancreatic adenocarcinomas

21 January 2018

1 reference

Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma

21 January 2018

1 reference

Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer

21 January 2018

1 reference

Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray

21 January 2018

1 reference

Actinin-4 expression in primary and metastasized pancreatic ductal adenocarcinoma

21 January 2018

1 reference

ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma

21 January 2018

1 reference

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

21 January 2018

1 reference

Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer

21 January 2018

1 reference

Cytokeratin 20 expression identifies a subtype of pancreatic adenocarcinoma with decreased overall survival.

21 January 2018

1 reference

Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer

21 January 2018

1 reference

High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma

21 January 2018

1 reference

Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma

21 January 2018

1 reference

Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

High mobility group AT-hook 1 (HMGA1) is an independent prognostic factor and novel therapeutic target in pancreatic adenocarcinoma

21 January 2018

1 reference

Expression of liver-intestine cadherin and its possible interaction with galectin-3 in ductal adenocarcinoma of the pancreas

21 January 2018

1 reference

Prognostic value of metastin expression in human pancreatic cancer.

21 January 2018

1 reference

MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas

21 January 2018

1 reference

Overexpression of sialyl Lewis x antigen is associated with formation of extratumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer

21 January 2018

1 reference

CD74 is a novel prognostic factor for patients with pancreatic cancer receiving multimodal therapy.

21 January 2018

1 reference

High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker

21 January 2018

1 reference

Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704.

21 January 2018

1 reference

Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers

21 January 2018

1 reference

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

21 January 2018

1 reference

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma

21 January 2018

1 reference

CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

21 January 2018

1 reference

Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia

21 January 2018

1 reference

LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.

21 January 2018

1 reference

Immunohistochemical localization of P-glycoprotein and expression of the multidrug resistance-1 gene in human pancreatic cancer: relevance to indicator of better prognosis.

21 January 2018

1 reference

High expression of TROP2 correlates with poor prognosis in pancreatic cancer.

21 January 2018

1 reference

Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma

21 January 2018

1 reference

The importance of cyclin D1 and Ki67 expression on the biological behavior of pancreatic adenocarcinomas

21 January 2018

1 reference

Significance of proliferative activity and DNA ploidy in pancreatic cancer and chronic pancreatitis

21 January 2018

1 reference

The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation.

21 January 2018

1 reference

Expression of survivin, a novel inhibitor of apoptosis and cell cycle regulatory protein, in pancreatic adenocarcinoma

21 January 2018

1 reference

Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas

21 January 2018

1 reference

Molecular pathogenesis of pancreatic cancer: advances and challenges

21 January 2018

1 reference

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

21 January 2018

1 reference

Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics

21 January 2018

1 reference

p27Kip1 expression is reduced in pancreatic carcinoma but has limited prognostic value

21 January 2018

1 reference

Prognostic value of p27 kip1 expression in adenocarcinoma of the pancreatic head region

21 January 2018

1 reference

Structural biology of the tumor suppressor p53.

21 January 2018

1 reference

Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.

21 January 2018

1 reference

Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival.

21 January 2018

1 reference

Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21(WAF1/CIP1) in pancreatic cancer

21 January 2018

1 reference

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma

21 January 2018

1 reference

Prognostic value of immunohistochemical expression of p53 in patients with pancreatic cancer

21 January 2018

1 reference

An immunohistochemical study of bcl-2 and p53 protein expression in pancreatic carcinomas

21 January 2018

1 reference

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions

21 January 2018

1 reference

DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer

21 January 2018

1 reference

Clinicopathological correlations of cyclooxygenase-2, MDM2, and p53 expressions in surgically resectable pancreatic invasive ductal adenocarcinoma.

21 January 2018

1 reference

Apoptotic index or a combination of Bax/Bcl-2 expression correlate with survival after resection of pancreatic adenocarcinoma.

21 January 2018

1 reference

Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract.

21 January 2018

1 reference

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

Basics of TGF-beta and pancreatic cancer

21 January 2018

1 reference

Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival.

21 January 2018

1 reference

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

21 January 2018

1 reference

bax, but not bcl-2, influences the prognosis of human pancreatic cancer

21 January 2018

1 reference

Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal human pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas.

21 January 2018

1 reference

Survivin expression and its clinical significance in pancreatic cancer

21 January 2018

1 reference

The effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinoma.

21 January 2018

1 reference

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care

21 January 2018

1 reference

Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma.

21 January 2018

1 reference

Vascular endothelial growth factor and DPC4 predict adjuvant therapy outcomes in resected pancreatic cancer.

21 January 2018

1 reference

Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival

21 January 2018

1 reference

Prognostic value of VEGF in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

Tumor size significantly correlates with postoperative liver metastases and COX-2 expression in patients with resectable pancreatic cancer

21 January 2018

1 reference

High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas.

21 January 2018

1 reference

Expression of vascular endothelial growth factors A and C in human pancreatic cancer

21 January 2018

1 reference

Delayed progression of pancreatic intraepithelial neoplasia in a conditional Kras(G12D) mouse model by a selective cyclooxygenase-2 inhibitor.

21 January 2018

1 reference

Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer

21 January 2018

1 reference

Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial

21 January 2018

1 reference

Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma

21 January 2018

1 reference

Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?

21 January 2018

1 reference

The S100A4 Metastasis Factor Regulates Cellular Motility via a Direct Interaction with Myosin-IIA

21 January 2018

1 reference

Induction of 18A2/mts1 gene expression and its effects on metastasis and cell cycle control

21 January 2018

1 reference

S100A4 contributes to the suppression of BNIP3 expression, chemoresistance, and inhibition of apoptosis in pancreatic cancer

21 January 2018

1 reference

The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor

21 January 2018

1 reference

Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.

21 January 2018

1 reference

RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells

21 January 2018

1 reference

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

21 January 2018

1 reference

What are the hallmarks of cancer?

21 January 2018

1 reference

Molecular prognostic markers in pancreatic cancer: a systematic review

21 January 2018

1 reference

Molecular prognostic factors in patients with pancreatic cancer.

21 January 2018

1 reference

Prognostic signature for pancreatic cancer: are we close?

21 January 2018

1 reference

Molecular predictive and prognostic markers in non-small-cell lung cancer.

21 January 2018

1 reference

Bcl-2 expression in pancreas development and pancreatic cancer progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BJS.7574

1 reference

24 August 2017

1 reference